Developing a First-void Urine-based Infection Model to Study HPV-specific Antibody-virion Interaction Before and After HPV Vaccination

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(3 sites)

Belgium

Antwerp University Hospital, Antwerp, Wilrijk

University Hospital Ghent, Ghent

University Hospital Leuven, Leuven